M/s. KamlaAmrut Pharmaceutical LLP, Survey No.: 53,56,57, Nr. KamlaAmrut Industrial Park, Indrad, Ta.: Kadi, Dist.: Mehsana, Gujarat - 382715, Susmita Roy, B pharm, M ...

Cipla ended the previous trading session at Rs 1529.1, reflecting a 0.5% increase, with 1,578,715 shares traded.

That means that we can maybe expect to see some price drops in a few years as competitors enter the market, but don’t hold out for any discounts this year. The next big innovation that companies ...

此次提出无效的是西普拉（中国） 医药有限公司，该公司是印度第二大药厂CIPLA（西普拉）的全资子公司，该公司在廉价抗艾滋和抗癌药物方面深受 ...

The growth prospects of the Indian economy are likely to improve in the forthcoming quarters and the Financial Year 2026 is expected to be better than FY25, driven by fiscal tailwinds, private ...

“A simple pill, perhaps together with a GLP1RA like semaglutide, is affordable and scalable to the millions of people with diabetes,” said Dr. Stewart. Reference: “Cycling alpha cells in regenerative ...

MONDAY, Dec. 30, 2024 (HealthDay News) -- It was a year in health news that will be hard to forget. As blockbuster weight-loss drugs known as GLP-1s made a sizable dent in the obesity epidemic, study ...

The first pill to slow down Alzheimer's disease is being analysed for potential use on the NHS Getty Professor Alistair Burns, former NHS clinical director for dementia, called the trial results ...

Your device does not support the audio. GLEN CARBON — A two-vehicle accident occurred on the northbound lanes of Illinois Route 159 at Illinois Highway 270 on Sunday, Dec. 29, 2024. The incident ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to make a decision on the drug called hydromethylthionine mesylate ...